
Latterell Venture Partners
Description
Latterell Venture Partners (LVP) is a well-established venture capital firm based in San Francisco, California, with a singular focus on the healthcare sector. Founded in 1990, the firm has built a long track record of investing in and supporting innovative companies across various sub-sectors of healthcare, including biopharmaceuticals, medical devices, diagnostics, and healthcare services. LVP's investment strategy is primarily centered on seed and early-stage opportunities, aiming to identify and nurture promising ventures from their nascent phases.
The firm's deep specialization in healthcare allows its team to leverage extensive industry knowledge and networks to provide strategic guidance to its portfolio companies. LVP seeks out companies that are developing groundbreaking technologies or services with the potential to significantly impact patient care and the broader healthcare ecosystem. Their approach involves active engagement with founders, offering not just capital but also operational expertise and strategic insights to help navigate the complex landscape of healthcare innovation.
Over its three decades of operation, Latterell Venture Partners has successfully raised and managed multiple funds, accumulating over $1 billion in capital under management. This substantial capital base enables LVP to make meaningful investments in its portfolio companies. Typically, LVP's initial check sizes for new investments range from $1 million to $10 million, reflecting their commitment to providing significant early-stage funding to help companies achieve critical milestones. The firm's disciplined investment approach and long-term perspective have contributed to a strong reputation within the healthcare venture capital community.
Investor Profile
Latterell Venture Partners has backed more than 55 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 15% of its total and boasts 20 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States, South Korea.
- Strong thematic focus on Health Care, Biotechnology, Medical Device.
- Typical check size: $1M – $10M.
Stage Focus
- Series B (35%)
- Series C (24%)
- Series A (22%)
- Series Unknown (11%)
- Series F (2%)
- Series G (2%)
- Series D (2%)
- Private Equity (2%)
- Series E (2%)
Country Focus
- United States (98%)
- South Korea (2%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Medical
- Pharmaceutical
- Therapeutics
- Biopharma
- Life Science
- Manufacturing
- Oncology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.